NITRIC-OXIDE AND SUPEROXIDE ANIONS IN VASCULAR REACTIVITY OF RENOVASCULAR HYPERTENSIVE RATS

The present study intends to define the role of the endothelium derive d relaxing factor nitric-oxide (EDRF-NO) and the reactive oxygen inter mediates in hypersensitivity to 5-hydroxytryptamine (5-HT) observed in abdominal aorta rings of two kidney-two clip hypertensive rats. Methy lene Blue (which blocks production of cGMP by EDRF-NO) and Nw-nitro-L- arginine (which inhibits EDRF-NO synthesis), both shifted 5-HT dose-re sponse curves to the left and completely abolished the differences in sensitivity to the agonist. The aortic perfusion with Krebs-Alcohol 20 % (v/v) suppressed vascular relaxation to Ach (10(-5) M) and also abol ished differences in sensitivity to 5-HT. These results suggest that a lower availability of EDRF-NO accounts for a higher 5-HT sensitivity in vessels of hypertensive rats. On the contrary, ridogrel (inhibitor of tromboxane-synthase and blocker of PGH(2) and TxA(2) receptors) did not suppress the hypersensitivity to 5-HT. In addition, since the sup eroxide anion (O-2(-)) inactivates EDRF-NO, the effects of Superoxide dismutase (SOD) and Catalase (CAT) added in the bath were analyzed. Si gnificant changes in sensitivity (P<0.005) were found only for vessels of hypertensive rats (SOD depressing and CAT increasing sensitivity t o 5-HT). Complementary, SOD activity was evaluated in the aorta homoge nates and was found to be significantly lower in the hypertensive rats [(differences between hypertensive and sham rats, mU. mg wet weight t issue(-1): 7 days after clipping, -183+/-67 (n=11), P<0.02; 21 days, - 160+/-70 (n=9), p<0.05]. Results would indicate: 1. Lower EDRF-NO avai lability in vessels of the hypertensive animals which would account fo r higher sensitivity to 5-HT; 2. Such a lower EDRF-NO might depend in part, upon its greater inactivation by O-2(-) anions; 3. A greater pre sence of O-2(-) anions in the vessels of hipertensive rats that might be favored by the lower SOD activity concentration in the vascular wal l.